Cholangiocarcinoma Analysis
Cholangiocarcinoma Analysis - Related Videos
05:22
Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma
0 Views •
2026
The protocol presents a step-by-step laparoscopic protocol for radical resection of Bismuth-Corlette type IIIb perihilar cholangiocarcinoma. The procedure integrates preoperative PTCD, complex vascular dissection and repair, and biliary reconstruction for application in high-volume hepatobiliary centers.
04:50
Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
0 Views •
2025
Perihilar cholangiocarcinoma (pCCA) is a highly malignant and aggressive tumor, with radical resection being the only curative treatment available. With continuous advancements in laparoscopic techniques and instruments, laparoscopic radical surgery for pCCA is now considered technically safe and feasible. However, due to the high complexity of the surgery and the lack of evidence-based clinical support, laparoscopic radical surgery for type IIIb pCCA is performed only in a few large...
09:19
Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma
0 Views •
Cited by 4 •
2022
Robotic resection of hepatic S4b, S5, and S1 using the Taj Mahal procedure is feasible and safe for selected patients with hilar cholangiocarcinoma. The step-by-step details for this surgery are presented here.
15:04
A Neuronal and Astrocyte Co-Culture Assay for High Content Analysis of Neurotoxicity
0 Views •
Cited by 46 •
2009
This article describes a novel protocol and reagent set designed for sensitive measurement of neurotoxic effects of compounds and treatments on co-cultures of neurons and astrocytes using high content analysis. Results demonstrate that high content analysis represents an exciting novel technology for neurotoxicity assessment.
10:39
Automated Analysis of Intracellular Phenotypes of Salmonella Using ImageJ
0 Views •
Cited by 3 •
2022
Salmonella invades and replicates inside intestinal epithelial cells both in Salmonella-specific vacuoles and free in the cytosol (hyper-replication). A high-throughput fluorescence microscopy-based protocol is described here to quantify the intracellular phenotypes of Salmonella by two complementary image analyses through ImageJ, reaching single-cell resolution and scoring.
FAQs
Each modality answers a different analytical question. Imaging evaluates the lesion and its extent, histopathology examines tissue and malignant biliary cells, immunohistochemistry supports cellular classification, and molecular profiling identifies genomic alterations. Interpreting these findings together is more informative than relying on one data type because structural, cellular, and genetic evidence can be compared during tumor characterization.
Anatomic classification separates tumors according to their location within the biliary system. This distinction helps researchers compare clinical behavior, progression, and tumor characteristics across disease categories. It also provides a framework for studying whether differences in origin are associated with distinct biological features, microenvironmental conditions, prognostic patterns, or treatment-relevant findings in cancer research.
Molecular profiling detects genomic alterations that may influence signaling and tumor growth. Linking these alterations with observed disease characteristics can clarify why tumors behave differently and can identify findings relevant to targeted or immune-based therapies. In research, this connection supports biomarker discovery and helps evaluate how molecular features relate to treatment response.
The tumor microenvironment provides context for interpreting how cholangiocarcinoma progresses and behaves. Comparing microenvironmental features among intrahepatic, perihilar, and distal tumors can reveal biological differences that are not captured by tumor classification alone. This perspective strengthens studies of progression, prognosis, biomarker discovery, and the development of more precise disease models.
A practical workflow brings together assessment of tumor origin, biological characteristics, extent, and clinical behavior. Imaging contributes information about distribution, while histopathology and immunohistochemistry support cellular evaluation and classification. Molecular profiling is then interpreted alongside these findings rather than in isolation, producing an integrated dataset for staging, prognosis, and research investigation.
The resulting evidence can support diagnosis, staging, prognosis, biomarker discovery, and selection of targeted or immune-based therapies. In cancer research, these outputs also help investigators compare tumor subtypes, connect genomic alterations with signaling and growth, and design studies that evaluate treatment response or refine models of cholangiocarcinoma.
Integrated findings create more precise models of cholangiocarcinoma by connecting location, malignant cellular features, tumor extent, microenvironment, and genomic alterations. These models can guide future clinical studies and help investigators formulate questions about progression, prognosis, biomarkers, and therapy selection. The value lies in combining complementary evidence into a coherent representation of disease.